All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the <scp>HALLMARK DUAL</scp> studyJia‐Horng Kao, Stephanie Noviello, Young‐Suk Lim et al.|Liver International|2016Cited by 28
Daclatasvir plus asunaprevir for <scp>HCV</scp> genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysisJia‐Horng Kao, Stephanie Noviello, Donald M. Jensen et al.|Liver International|2015Cited by 16